Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Radiotherapy in Locally-Advanced Anal Squamous Cell Carcinoma
NCT05838391Recruiting
- Sponsor
- Columbia University
- Start
- May 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in anal squamous cell carcinoma (SCCA), sponsored by Columbia University. Primary endpoint: Time to plan and deliver treatment fractions up to 6 weeks. Started May 2023; status: recruiting.
02
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT05838391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838391.